Burning Rock Biotech Limited Receivables Turnover Ratio (BNR), from the fourth quarter 2025 to the fourth quarter 2024 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Burning Rock Biotech Limited  (NASDAQ: BNR)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Burning Rock Biotech Limited Accounts Receivables Turnover Ratio from the fourth quarter 2025 to the fourth quarter 2024

Quarterly Results, Trends, Rankings, Statistics


Burning Rock Biotech Limited's ability to collect accounts receivable sequentially worsen to 2.93, pointing to a challenging and on top of that deteriorating business climate for the Medical Laboratories industry. Burning Rock Biotech Limited's Accounts Receivable average collection period in the Dec 31 2025 quarter, has increased to 125 days, from 103 days, in the 0 quarter.

If we take a look into Healthcare sector 520 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from 1858 to 3563.

What is Receivable Turnover Ratio?
What is Burning Rock Biotech Limited Selling?


What is Receivable Turnover Ratio?





BNR Receivables Turnover Ratio (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2024)
IV. Quarter
Y / Y Receivable Change 398.96 % 16.46 % 16.46 % 16.46 % 24.7 %
Y / Y Revenue Change 9.18 % - - - -6.64 %
Receivable Turnover Ratio (TTM) 2.93 3.56 3.72 3.9 4.09
BNR's Total Ranking # 3563 # 1858 # # #
Accounts Receivable average collection period days 125 102 98 94 89
Seq. Receivable Change 34.93 % 0 % 0 % 269.78 % -68.51 %
Seq. Revenue Change - - - - -


Receivable Turnover Company Ranking
Within: No.
Medical Laboratories Industry # 37
Healthcare Sector # 521
Overall Market # 3563

Receivable Turnover Ratio Statistics
High Average Low
5.51 4.34 2.93
(Dec 31 2021)   (Dec 31 2025)






Financial Statements
Burning Rock Biotech Limited's Accounts Receivable $ 33 Millions Visit BNR's Balance sheet
Burning Rock Biotech Limited's Sales TTM $ 77 Millions Visit BNR's Income Statement
Sources of BNR's Revenues Visit BNR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
BNR's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
BNR's Growth Rates BNR's Roa BNR's Inventory Turnover Ratio BNR's Dividend Comparisons
BNR's Profitability Ratios BNR's Roi BNR's Asset Turnover Ratio BNR's Dividend Growth
BNR's Valuation Ratios BNR's Roe BNR's Financial Strength Ratios BNR's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Receivable at quarter ending Dec 31 2025
Nano X Imaging Ltd  6.47 $ 13.021  Millions$ 2.013  Millions
Pulmonx Corporation  6.47 $ 90.139  Millions$ 13.937  Millions
Astrazeneca Plc  6.46 $ 58,739.000  Millions$ 9,093.750  Millions
Stryker Corp  6.46 $ 25,116.000  Millions$ 3,890.250  Millions
Stereotaxis Inc   6.45 $ 32.071  Millions$ 4.974  Millions
Cvrx inc   6.43 $ 56.340  Millions$ 8.760  Millions
Concord Medical Services Holdings Ltd  6.43 $ 65.852  Millions$ 10.239  Millions
Harvard Bioscience Inc   6.42 $ 85.910  Millions$ 13.392  Millions
Intellia Therapeutics Inc   6.39 $ 67.671  Millions$ 10.594  Millions
Opko Health Inc   6.38 $ 606.879  Millions$ 95.090  Millions
Lakeland Industries Inc   6.37 $ 192.648  Millions$ 30.221  Millions
Bruker Corporation  6.37 $ 3,435.700  Millions$ 539.050  Millions
Baxter International Inc   6.37 $ 11,244.000  Millions$ 1,764.250  Millions
Catalyst Pharmaceuticals Inc   6.37 $ 588.989  Millions$ 92.504  Millions
Pacira Biosciences inc   6.34 $ 726.411  Millions$ 114.612  Millions
Ardelyx inc   6.33 $ 407.320  Millions$ 64.370  Millions
Adm Tronics Unlimited Inc   6.31 $ 3.414  Millions$ 0.541  Millions
Anaptysbio Inc   6.30 $ 234.603  Millions$ 37.209  Millions
Seastar Medical Holding Corp  6.29 $ 1.234  Millions$ 0.196  Millions
Zoetis Inc   6.28 $ 9,467.000  Millions$ 1,508.000  Millions
Sangamo Therapeutics Inc   6.27 $ 39.552  Millions$ 6.306  Millions
Liquidia Corporation  6.25 $ 158.320  Millions$ 25.317  Millions
Elutia Inc   6.25 $ 17.639  Millions$ 2.824  Millions
Vertex Pharmaceuticals Inc  6.24 $ 12,001.300  Millions$ 1,924.450  Millions
Treace Medical Concepts Inc   6.23 $ 212.690  Millions$ 34.139  Millions
Embecta Corp   6.23 $ 1,079.400  Millions$ 173.325  Millions
Select Medical Holdings Corp  6.22 $ 5,452.830  Millions$ 876.916  Millions
Strata Critical Medical Inc   6.17 $ 197.126  Millions$ 31.949  Millions
Nuwellis Inc   6.16 $ 8.270  Millions$ 1.342  Millions
Labcorp Holdings Inc   6.15 $ 13,951.700  Millions$ 2,269.275  Millions

Date modified: 2026-07-07T09:40:27+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.